Amarin (AMRN), a constituent stock, fell by 17.91%. Other constituent stocks, Summit Therapeutics Plc., 23Andme Holding Co., and Janux Therapeutics, fell by 17.36%-11.75%. Humacyte also fell by 9.50%. Hutchmed (China) (HCM) rose by 6.49%, Twist Bioscience rose by 6.75%, Zai Lab (ZLAB) rose by 7.17%, Agios Pharmaceuticals rose by 8.03%, and Olema also rose by 18.96%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.